| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |